Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 2653

Sort by

Sort Order Select

Journal Articles

Novel Mechanisms of Resistance in CLL: Variant BTK Mutations in Second-Generation and Noncovalent BTK Inhibitors

Constantine S. Tam, Shalini Balendran, Piers Blombery

Blood blood.2024026672.

https://doi.org/10.1182/blood.2024026672

Published: 2025

Journal Articles

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma

Blood blood.2024025500.

https://doi.org/10.1182/blood.2024025500

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes in patients with ETV6 :: RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies

Katelyn Purvis, Yinmei Zhou, Seth E. Karol, Jeffrey E. Rubnitz, Raul C. Ribeiro, Shawn Lee, Jun J. Yang, W. Paul Bowman, Lu Wang, Stephanie B. Dixon, Kathryn G. Roberts, Qingsong Gao, Cheng Cheng, Charles G. Mullighan, Sima Jeha, Ching-Hon Pui, Hiroto Inaba

Blood (2025) 145 (2): 190–201.

https://doi.org/10.1182/blood.2024024936

Published: 2025

Includes: Supplemental data

Journal Articles

The current landscape of frontline large B-cell lymphoma trials

David Qualls, Philippe Armand, Gilles Salles

Blood (2025) 145 (2): 176–189.

https://doi.org/10.1182/blood.2023023789

Published: 2025

Journal Articles

Building the future management of follicular lymphoma with T-cell–redirecting strategies

Gloria Iacoboni, Franck Morschhauser

Blood (2025) 145 (2): 170–175.

https://doi.org/10.1182/blood.2024025699

Published: 2025

Includes: Supplemental data

Journal Articles

CD123 to the rescue

Anisha Elizabeth Jacob, Girish Venkataraman

Blood (2025) 145 (2): 248.

https://doi.org/10.1182/blood.2024026030

Published: 2025

Journal Articles

Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy

David G. Coffey, Pinar Ataca Atilla, Erden Atilla, Ola Landgren, Andrew J. Cowan, Sylvain Simon, Margot J. Pont, Melissa L. Comstock, Geoffrey R. Hill, Stanley R. Riddell, Damian J. Green

Blood (2025) 145 (2): 220–233.

https://doi.org/10.1182/blood.2024025231

Published: 2025

Includes: Supplemental data

Journal Articles

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma

Blood (2025) 145 (2): 202–219.

https://doi.org/10.1182/blood.2024025987

Published: 2025

Includes: Supplemental data

Journal Articles

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragment covalently deposited on lymphoma cells

Blood blood.2024024846.

https://doi.org/10.1182/blood.2024024846

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting Senescent Stemlike Subpopulations in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia

Blood blood.2024026482.

https://doi.org/10.1182/blood.2024026482

Published: 2025

Includes: Supplemental data

Journal Articles

How I treat ETP-ALL in children

Ryan J. Summers, David T. Teachey, Stephen P. Hunger

Blood (2025) 145 (1): 43–52.

https://doi.org/10.1182/blood.2023023155

Published: 2025

Journal Articles

How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adults

Thai Hoa Tran, Sarah K. Tasian

Blood (2025) 145 (1): 20–34.

https://doi.org/10.1182/blood.2023023153

Published: 2025

Journal Articles

How I treat infant acute lymphoblastic leukemia

Jack Bartram, Philip Ancliff, Ajay Vora

Blood (2025) 145 (1): 35–42.

https://doi.org/10.1182/blood.2023023154

Published: 2025

Journal Articles

How I treat postimmunotherapy relapsed B-ALL

Adam J. Lamble, Alexandra E. Kovach, Nirali N. Shah

Blood (2025) 145 (1): 64–74.

https://doi.org/10.1182/blood.2024024517

Published: 2025

Journal Articles

How I treat adult Ph + ALL

Sabina Chiaretti, Robin Foà

Blood (2025) 145 (1): 11–19.

https://doi.org/10.1182/blood.2023023152

Published: 2025

Journal Articles

Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Rahul Banerjee, Rachael Sexton, Andrew J. Cowan, Aaron S. Rosenberg, Sikander Ailawadhi, S. Vincent Rajkumar, Shaji Kumar, Angela Dispenzieri, Sagar Lonial, Brian G. M. Durie, Paul G. Richardson, Saad Z. Usmani, Antje Hoering, Robert Z. Orlowski

Blood (2025) 145 (1): 75–84.

https://doi.org/10.1182/blood.2024025939

Published: 2025

Includes: Supplemental data

Journal Articles

How I treat older patients with Ph/BCR-ABL–negative acute lymphoblastic leukemia

Nicola Gökbuget, Björn Steffen

Blood (2025) 145 (1): 53–63.

https://doi.org/10.1182/blood.2023023156

Published: 2025

Journal Articles

Introduction to a How I Treat series on acute lymphoblastic leukemia

Hervé Dombret

Blood (2025) 145 (1): 1–2.

https://doi.org/10.1182/blood.2024026463

Published: 2025

Journal Articles

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Blood (2025) 145 (1): 85–97.

https://doi.org/10.1182/blood.2024025945

Published: 2025

Includes: Supplemental data

Journal Articles

High-Risk MCL: Recognition and Treatment

Preetesh Jain, Michael L Wang

Blood blood.2023022354.

https://doi.org/10.1182/blood.2023022354

Published: 2024

NARROW

Novel Mechanisms of Resistance in CLL: Variant BTK Mutations in Second-Generation and Noncovalent BTK Inhibitors

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma

Outcomes in patients with ETV6 :: RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies

The current landscape of frontline large B-cell lymphoma trials

Building the future management of follicular lymphoma with T-cell–redirecting strategies

CD123 to the rescue

Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragment covalently deposited on lymphoma cells

Targeting Senescent Stemlike Subpopulations in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia

How I treat ETP-ALL in children

How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adults

How I treat infant acute lymphoblastic leukemia

How I treat postimmunotherapy relapsed B-ALL

How I treat adult Ph + ALL

Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

How I treat older patients with Ph/BCR-ABL–negative acute lymphoblastic leukemia

Introduction to a How I Treat series on acute lymphoblastic leukemia

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

High-Risk MCL: Recognition and Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only